Aliskiren

RASILEZ 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

300 mg comprimido recubierto con películaSpainAuthorisedAuthorised 14 Jan 2010

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Aliskiren

RASILEZ 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

300 mg comprimido recubierto con películaSpainAuthorisedAuthorised 14 Jan 2010

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rasilez 150MG F.C. TabletsSaudi Arabia · Novartis

Rasilez 300MG F.C. TabletsSaudi Arabia · Novartis

Sandoz AliskirenCanada · 150 MG · Tablet · Sandoz Canada Incorporated

EnviageEuropean Union · Novartis Europharm Ltd.

RiprazoEuropean Union · Novartis Europharm Ltd.

Packs

Pack	Code	Status
RASILEZ 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos	664471

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Aliskiren
Strength: 300 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 14 Jan 2010
Registration: 07405013IP
Marketing authorisation holder: Novartis Europharm Limited
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

Spain

RASILEZ 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAliskiren · 150 mg · comprimido recubierto con películaSpain

RASILEZ 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAliskiren · 300 mg · comprimido recubierto con películaSpain